Sign in

CIK 0001689375

  • Accelerated filer
  • Smaller reporting company
  • Emerging growth company

Entrada Therapeutics, Inc.

Sign in to watch
Ticker
TRDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813983399
Phone
+1 857-305-1825
Business address
ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
Former names
CycloPorters, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$7,200,939
in 8 filings

Net −$7,200,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 21 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-02 WENTWORTH KORY JAMES Chief Financial Officer Sale −1,602 $10.46 $17K 42,302
2023-03-02 WENTWORTH KORY JAMES Chief Financial Officer Sale −145 $11.23 $2K 42,157
2023-03-02 Sethuraman Natarajan Chief Scientific Officer Shares withheld for taxes −1,058 $11.60 $12K 189,486
2023-03-02 Doshi Dipal President and CEO Shares withheld for taxes −3,324 $11.60 $39K 257,811
2023-03-02 Dowden Nathan J Chief Operating Officer Shares withheld for taxes −1,028 $11.60 $12K 72,655
2023-03-02 KREHER NERISSA Chief Medical Officer Shares withheld for taxes −945 $11.60 $11K 42,971
2023-03-02 KREHER NERISSA Chief Medical Officer Sale −1,477 $10.49 $15K 41,494
2023-03-02 KREHER NERISSA Chief Medical Officer Sale −164 $11.22 $2K 41,330
2023-03-01 Doshi Dipal President and CEO Grant or award +49,650 206,161
2023-03-01 Doshi Dipal President and CEO Grant or award · Stock Option (Right to Buy) +75,250 75,250
2023-03-01 Sethuraman Natarajan Chief Scientific Officer Grant or award +14,200 175,286
2023-03-01 Sethuraman Natarajan Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +21,500 21,500
2023-03-01 WENTWORTH KORY JAMES Chief Financial Officer Grant or award +14,200 27,957
2023-03-01 WENTWORTH KORY JAMES Chief Financial Officer Grant or award · Stock Option (Right to Buy) +21,500 21,500
2023-03-01 KREHER NERISSA Chief Medical Officer Grant or award +14,200 27,130
2023-03-01 KREHER NERISSA Chief Medical Officer Grant or award · Stock Option (Right to Buy) +21,500 21,500
2023-03-01 Dowden Nathan J Chief Operating Officer Grant or award +14,200 58,455
2023-03-01 Dowden Nathan J Chief Operating Officer Grant or award · Stock Option (Right to Buy) +21,500 21,500
2023-03-01 WENTWORTH KORY JAMES Chief Financial Officer Grant or award +28,400 44,909
2023-03-01 WENTWORTH KORY JAMES Chief Financial Officer Grant or award · Stock Option (Right to Buy) +43,000 43,000

Page 17 of 26 · 517 trades